Skip to main content

Synomics Announces New Integration Architecture


CAMBRIDGE, UK--Synomics has launched Alliance, a software integration architecture system that the company said is designed to allow the life sciences industry to implement a "sustainable" integration strategy and deliver integrated R&D applications to the desktop. The products' integration capabilities can combine existing resources and proprietary knowledge and enable scientists and technical staff to collaborate more effectively, building upon past investments in systems and data. Alliance also allows databases and analysis tools to be linked, enabling the integration of desktop applications. The scope and functions of the user interfaces can be extended as required to meet scientists' changing research needs, the company said.

Filed under

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.